IP Library Granted Patent US 12692393
Granted Patent B2
US 12692393 · App. 18/651,748 · Granted Jul 28, 2026

Zwitterionic polysiloxane for biomedical devices

Inventors: William R. Wagner (Gibsonia, PA); Sang Ho Ye (Cheswick, PA); Seungil Kim (Pittsburgh, PA); Sung Kwon Cho (Pittsburgh, PA)
Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
C08L83/04C08G77/06C08K5/17
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12692393
App. No.
18/651,748
Filed
May 1, 2024
Granted
Jul 28, 2026
Kind
B2
Art Unit
1762
USPC
524/731
Abstract

A zwitterionic polysiloxane polymer (e.g., a polyurethane elastomer) composition having poly(dialkylsiloxane) blocks and a zwitterionic moiety is prepared by the copolymerization of a poly(dialkylsiloxane) diol, a diisocyanate, a tertiary amine alkyl diol, and a poly(dialkylsiloxane) diamine to form a poly(urethane urea) copolymer. A substituted saturated heterocylic compound is reacted with the tertiary amine of the poly(urethane urea) copolymer to introduce a zwitterionic group into the poly(urethane urea) copolymer backbone. A polysiloxane polymer having a zwitterionic moiety is prepared by reacting a diallyl tertiary amine compound and a substituted saturated heterocylic compound to form a diallyl zwitterionic macromer and cross-linking a vinyl terminated poly(dialkylsiloxane) and the diallyl zwitterionic macromer with a curing agent to introduce a zwitterionic group into the poly(dialkylsiloxane) polymer.

Claims (20)

1 . A method of preparing a polysiloxane composition comprising a zwitterionic moiety, the method comprising:

reacting a diallyl tertiary amine compound with a substituted saturated heterocyclic compound to produce a diallyl zwitterionic monomer, mixing a vinyl-terminated poly(dialkylsiloxane) and the diallyl zwitterionic monomer with a curing agent, and curing the mixture to introduce a zwitterionic group into the poly(dialkylsiloxane); or

mixing a vinyl-terminated poly(dialkylsiloxane) and a diallyl tertiary amine compound with a curing agent, curing the mixture to form a cross-linked tertiary amine-modified poly(dialkylsiloxane), and reacting the cross-linked tertiary amine-modified poly(dialkylsiloxane) with a substituted saturated heterocyclic compound to introduce a zwitterionic group into the cross-linked tertiary amine-modified poly(dialkylsiloxane).

2 . The method of claim 1 , comprising: reacting a diallyl tertiary amine compound with a substituted saturated heterocyclic compound to produce a diallyl zwitterionic monomer, mixing a vinyl-terminated poly(dialkylsiloxane) and the diallyl zwitterionic monomer with a curing agent, and curing the mixture to introduce a zwitterionic group into the poly(dialkylsiloxane).

3 . The method of claim 2 , wherein a molar ratio of vinyl-terminated poly(dialkylsiloxane) to the diallyl zwitterionic monomer is 1-5:1-12.

4 . The method of claim 1 , comprising:

mixing a vinyl-terminated poly(dialkylsiloxane) and a diallyl tertiary amine compound with a curing agent;

curing the mixture to form a cross-linked tertiary amine-modified poly(dialkylsiloxane); and

reacting the cross-linked tertiary amine-modified poly(dialkylsiloxane) with a substituted saturated heterocyclic compound to introduce a zwitterionic group into the cross-linked tertiary amine-modified poly(dialkylsiloxane).

5 . The method of claim 4 , wherein the diallyl tertiary amine compound has the structure:

wherein R 4 , and R 5 , are independently

where n is at least one, and R 6 is linear alkyl.

6 . The method of claim 1 , wherein the substituted saturated heterocyclic compound is selected from:

7 . The method of claim 1 , further comprising coating or fabricating an article with the polysiloxane composition, wherein the article optionally is a blood-contacting article.

8 . The method of claim 7 , wherein the blood-contacting article is a stent, a coil, a catheter, a vascular graft, an artificial valve, a gas-permeable membrane, or a microfluidic device.

9 . The method of claim 2 , wherein the diallyl tertiary amine compound has the structure:

wherein R 4 , and R 5 , are independently

where n is at least one, and R 6 is linear alkyl.

10 . The method of claim 4 , wherein a molar ratio of vinyl-terminated poly(dialkylsiloxane) to the diallyl tertiary amine compound is 1-5:1-12.

11 . The method of claim 1 , wherein the vinyl-terminated poly(dialkylsiloxane) comprises one or more of: a dimethyl siloxane; a diphenylsiloxane; a diethylsiloxane; a trifluoropropyl methyl siloxane; a phenylmethylsiloxane; a copolymer of dimethylsiloxane with one or more of a diphenylsiloxane, a diethylsiloxane, a trifluoropropyl methyl siloxane, a phenylmethylsiloxane; and/or an aminopropylmethylsiloxane-(dimethylsiloxane).